These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression. Coffing H, Priyamvada S, Anbazhagan AN, Salibay C, Engevik M, Versalovic J, Yacyshyn MB, Yacyshyn B, Tyagi S, Saksena S, Gill RK, Alrefai WA, Dudeja PK. Am J Physiol Gastrointest Liver Physiol; 2018 Jul 01; 315(1):G43-G52. PubMed ID: 29597352 [Abstract] [Full Text] [Related]
6. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Zhang Y, Yang Z, Gao S, Hamza T, Yfantis HG, Lipsky M, Feng H. Anaerobe; 2017 Dec 01; 48():249-256. PubMed ID: 29031928 [Abstract] [Full Text] [Related]
7. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection. Warren CA, Li Y, Calabrese GM, Freire RS, Zaja-Milatovic S, van Opstal E, Figler RA, Linden J, Guerrant RL. Infect Immun; 2012 Dec 01; 80(12):4463-73. PubMed ID: 23045479 [Abstract] [Full Text] [Related]
9. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early Clostridioides difficile toxin exposure. Ok MT, Liu J, Bliton RJ, Hinesley CM, San Pedro EET, Breau KA, Gomez-Martinez I, Burclaff J, Magness ST. Am J Physiol Gastrointest Liver Physiol; 2023 Apr 01; 324(4):G262-G280. PubMed ID: 36749911 [Abstract] [Full Text] [Related]
10. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model. Yang XQ, Zhao YG, Chen XQ, Jiang B, Sun DY. BMC Gastroenterol; 2013 Jul 17; 13():117. PubMed ID: 23865596 [Abstract] [Full Text] [Related]
13. Extra-Intestinal Effects of C.difficile Toxin A and B: An In Vivo Study Using the Zebrafish Embryo Model. Tonon F, Di Bella S, Grassi G, Luzzati R, Ascenzi P, di Masi A, Zennaro C. Cells; 2020 Dec 01; 9(12):. PubMed ID: 33271969 [Abstract] [Full Text] [Related]
14. Murine Intrarectal Instillation of Purified Recombinant Clostridioides difficile Toxins Enables Mechanistic Studies of Pathogenesis. Markham NO, Bloch SC, Shupe JA, Laubacher EN, Thomas AK, Kroh HK, Childress KO, Peritore-Galve FC, Washington MK, Coffey RJ, Lacy DB. Infect Immun; 2021 Mar 17; 89(4):. PubMed ID: 33468584 [Abstract] [Full Text] [Related]
15. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling. Chen X, Yang X, de Anda J, Huang J, Li D, Xu H, Shields KS, Džunková M, Hansen J, Patel IJ, Yee EU, Golenbock DT, Grant MA, Wong GCL, Kelly CP. Gastroenterology; 2020 Dec 17; 159(6):2181-2192.e1. PubMed ID: 32841647 [Abstract] [Full Text] [Related]
16. P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice. Santos AAQA, Costa DVS, Foschetti DA, Duarte ASG, Martins CS, Soares PMG, Castelucci P, Brito GAC. World J Gastroenterol; 2022 Aug 14; 28(30):4075-4088. PubMed ID: 36157120 [Abstract] [Full Text] [Related]
17. Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis. Engevik MA, Danhof HA, Chang-Graham AL, Spinler JK, Engevik KA, Herrmann B, Endres BT, Garey KW, Hyser JM, Britton RA, Versalovic J. Am J Physiol Gastrointest Liver Physiol; 2020 May 01; 318(5):G870-G888. PubMed ID: 32223302 [Abstract] [Full Text] [Related]
18. P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells. Grbic DM, Degagné É, Larrivée JF, Bilodeau MS, Vinette V, Arguin G, Stankova J, Gendron FP. Inflamm Bowel Dis; 2012 Aug 01; 18(8):1456-69. PubMed ID: 22095787 [Abstract] [Full Text] [Related]